HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mukesh Samant Selected Research

Interleukin-12 (IL 12)

2/2012Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
1/2009Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.
10/2008Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mukesh Samant Research Topics

Disease

12Visceral Leishmaniasis (Kala Azar)
01/2021 - 03/2008
4COVID-19
09/2022 - 09/2020
4Infections
01/2021 - 01/2012
3Hypersensitivity (Allergy)
10/2020 - 10/2008
2Leishmaniasis
12/2022 - 10/2020
2Neoplasms (Cancer)
06/2022 - 12/2021
2Virus Diseases (Viral Diseases)
12/2021 - 12/2020
2Human Influenza (Influenza)
09/2014 - 02/2012
1Parasitic Diseases (Parasitic Disease)
12/2022
1Inflammation (Inflammations)
12/2021
1Disease Progression
01/2021
1Severe Acute Respiratory Syndrome
12/2020
1Necrosis
02/2012
1Porphyrias (Porphyria)
01/2009

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
12/2022 - 03/2008
4Pharmaceutical PreparationsIBA
12/2022 - 11/2008
3CytokinesIBA
12/2021 - 02/2012
3Interleukin-12 (IL 12)IBA
02/2012 - 10/2008
2Interleukin-17 (Interleukin 17)IBA
12/2021 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 02/2012
2Antiviral Agents (Antivirals)IBA
12/2020 - 09/2020
2Attenuated VaccinesIBA
10/2020 - 01/2020
2AntigensIBA
10/2020 - 10/2008
2DNA (Deoxyribonucleic Acid)IBA
05/2020 - 07/2009
2Inactivated VaccinesIBA
09/2014 - 02/2012
2Immunoglobulin G (IgG)IBA
01/2009 - 10/2008
1EnzymesIBA
12/2022
1Synthetic DrugsIBA
06/2022
1Angiotensin-Converting Enzyme 2IBA
08/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2020
1Biological ProductsIBA
12/2020
1Viral ProteinsIBA
12/2020
1DEAD-box RNA HelicasesIBA
10/2020
1Biomarkers (Surrogate Marker)IBA
05/2020
1Plant ExtractsIBA
09/2019
1Interleukin-4 (Interleukin 4)IBA
02/2012
1miltefosine (Impavido)IBA
02/2012
1InterferonsIBA
02/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012
1DNA VaccinesIBA
07/2009
1Heme (Haem)IBA
01/2009
1vasicineIBA
11/2008
1Subunit VaccinesIBA
10/2008
1Proteins (Proteins, Gene)FDA Link
10/2008
1PolyproteinsIBA
10/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2022 - 10/2020
1Immunotherapy
12/2021
1Therapeutics
03/2008